For research use only. Not for therapeutic Use.
Eltrombopag Olamine is an orally administered thrombopoietin receptor agonist used in the treatment of thrombocytopenia associated with chronic immune thrombocytopenic purpura (ITP) and thrombocytopenia related to chronic hepatitis C infection. It works by stimulating the thrombopoietin receptor, leading to increased platelet production. This selective activation of the receptor aids in the management of platelet counts in patients with insufficient platelet production. Eltrombopag Olamine is critical for individuals requiring alternative therapeutic options for platelet management in hematologic conditions.
| Catalog Number | A000808 |
| CAS Number | 496775-62-3 |
| Synonyms | B-497115-GR, SB497115 |
| Molecular Formula | C29H36N6O6 |
| Purity | ≥95% |
| Target | Anti-infection |
| Solubility | Soluble in DMSO |
| Storage | 3 years -20 ℃ |
| IUPAC Name | 2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid |
| InChI | 1S/C25H22N4O4.2C2H7NO/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33;2*3-1-2-4/h4-13,28,30H,1-3H3,(H,32,33);2*4H,1-3H2 |
| InChIKey | DJMJHIKGMVJYCW-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N |
